Welcome to LookChem.com Sign In|Join Free

CAS

  • or

72158-53-3

Post Buying Request

72158-53-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72158-53-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 72158-53-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,1,5 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 72158-53:
(7*7)+(6*2)+(5*1)+(4*5)+(3*8)+(2*5)+(1*3)=123
123 % 10 = 3
So 72158-53-3 is a valid CAS Registry Number.

72158-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 9H-Purin-6-amine, N-[(3-iodophenyl)methyl]-

1.2 Other means of identification

Product number -
Other names N6-(3-iodobenzyl)adenine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72158-53-3 SDS

72158-53-3Downstream Products

72158-53-3Relevant articles and documents

Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)

-

Paragraph 0051-0052, (2014/10/16)

The present invention relates to a method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) and the use of the compounds in the prevention or treatment of disease, including pre-diabetes, type 2 diabetes, syndrome X, metabolic syndrome and obesity.

Structure-Activity Relationships of 9-Alkyladenine and Ribose-Modified Adenosine Derivatives at Rat A3 Adenosine Receptors

Jacobson, Kenneth A.,Siddiqi, Suhaib M.,Olah, Mark E.,Ji, Xiao-duo,Melman, Neli,et al.

, p. 1720 - 1735 (2007/10/02)

9-Alkyladenine derivatives and ribose-modified N6-benzyladenosine derivatives were synthesized in an effort to identify selective ligands for the rat A3 adenosine receptor and leads for the development of antagonists.The derivatives

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 72158-53-3